Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at thehindu.com →

More in Health & Medicine

More from Friday 14 August →